Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis
Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis
复制标题
DOI:
10.1021/ja010129o
复制
发表时间:
2001-06-06
影响因子:
15
通讯作者:
Carter, GT
中科院分区:
文献类型:
--
作者:
He, HY;Ding, WD;Carter, GT
An earlier study on the marine ascidian Polysyncraton lithostrotum resulted in the isolation of a potent antitumor compound, namenamicin. 1 Because of the remarkable similarity of its enediyne aglycon to that found in the actinomycete-derived calicheamicins2 and esperamicins, 3 it was suspected that the real producer of the namenamicin could be a microbial symbiont. Therefore, a number of actinomycetes were isolated from the inner core of the host ascidian to answer the question of compound origin. 4Among these actinomycetes, a halophilic strain, LL-37I366, was identified as a new species of the genus Micromonospora on the basis of its morphological properties and 16S rDNA sequence, and was named “Micromonospora lomaiVitiensis”. 5 The fermentation broth of this organism exhibited potent DNA-damaging activity indicated by the biochemical induction assay (BIA) 6 and was extremely cytotoxic against a panel of cancer cell lines. 7 Using BIA-guided fractionation, two novel dimeric diazobenzofluorene glycosides were isolated and designated lomaiviticins A (1) and B (2)(Figures 1 and 3). In this paper, the production, isolation, structural elucidation, and biological activity of the new antibiotics are reported. Lomaiviticins A (1) and B (2) were produced by fermentation of strain LL-37I366 in a seawater medium in the presence of HP20 resin. The pink colored mixture adsorbed on the resin was extracted with acidic acetonitrile and separated by HPLC to afford the pure antibiotics 1 and 2 (experimental and spectroscopic data, see Supporting Information).